Scientists synthesize a prebiotic carrier assists regorafenib in treating colorectal cancer

In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences developed an oral molecular targeted drug delivery system based on an inulin derivative, which combines gut microbiota modulation with precise drug delivery, enhancing colorectal cancer (CRC) therapy.